Aphios Pharma Cannabis Drugs Cancer Pain Opioid Addiction MS

Aphios Pharma develops cannabis and hemp-based pharmaceutical drugs targeting cancer pain, opioid use disorder, and multiple sclerosis using novel drug delivery technologies. The company follows the FDA 505b(2) regulatory pathway to accelerate development and advance to Phase 2 clinical trials. Backed by Harvard Medical School expertise, Aphios combines natural cannabinoids with scientific rigor for nervous system disorder treatments.